Try our beta test site
1 study found for:    MERTK
Show Display Options
Rank Status Study
1 Recruiting Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients With Retinal Disease Due to MERTK Mutations
Condition: Retinal Disease
Intervention: Genetic: Recombinant Adeno-Associated Virus

Study has passed its completion date and status has not been verified in more than two years.